Indrayani Biotech Quarterly Results for Trading Insights
In Mar 2026, Indrayani Biotech (INDRANIB) reported revenue ₹39 Cr and net profit ₹1 Cr — revenue -26.4% YoY. Analyse INDRANIB shareholder distribution to track promoter, FII and institutional holdings.
INDRANIB Quarterly Results — Revenue, Profit & EPS Highlights
Indrayani Biotech latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. For annual financials, live price and key ratios, visit Indrayani Biotech share price chart.
- Revenue of ₹39 Cr in Mar 2026 (+2.6% vs Sept 2025, -26.4% vs Mar 2025)
- Net Profit of ₹1 Cr in Mar 2026 (+0.0% vs Sept 2025, +111.1% vs Mar 2025)
- EBITDA of ₹3 Cr in Mar 2026 (-25.0% vs Sept 2025)
- Operating Margin of 6.0% in Mar 2026 (-1.0pp vs Sept 2025)
- Earnings Per Share of ₹0.24 in Mar 2026 (+166.7% vs Sept 2025)
Indrayani Biotech Quarterly Results — Revenue, EBITDA, Net Profit & EPS
INDRANIB quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.
| Metric | Mar 2026 | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 39 | 38 | 53 | 30 | 36 | 2.6% | -26.4% |
| Net Profit (₹ Cr) | 1 | 1 | -9 | 0 | 0 | - | - |
| EBITDA (₹ Cr) | 3 | 4 | -3 | 3 | 4 | - | - |
| EPS (₹) | 0.24 | 0.09 | -1.88 | 0.03 | 0.03 | - | - |
| Operating Margin (%) | 6.0% | 7.0% | -11.0% | 7.0% | 8.0% | - | - |
INDRANIB Share Price Trend — 1-Year Movement Across Quarterly Results
Indrayani Biotech 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. View INDRANIB price range for the annual high/low range and current price position.
Revenue Trend (₹ Cr)
Net Profit Trend (₹ Cr)
Operating Margin Trend (%)
INDRANIB vs FMCG Peers — Quarterly Revenue, Profit & Market Cap
Indrayani Biotech latest quarter revenue and net profit vs FMCG competitors — market cap, price and earnings comparison.
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Hindustan Unilever
Mar 2026 |
₹453,941.03 Cr | 1932.0 | 16,718 | 2,994 | -3.8% | - | 17.9% | 151.8 |
|
ITC
Mar 2026 |
₹328,647.95 Cr | 262.3 | 18,354 | 5,470 | -8.9% | - | 29.8% | 61.0 |
|
Marico
Mar 2026 |
₹104,142.69 Cr | 803.9 | 3,361 | 408 | -16.1% | - | 12.1% | 264.4 |
|
Patanjali Foods
Mar 2026 |
₹39,933.59 Cr | 367.0 | 11,212 | 524 | -1.1% | - | 4.7% | 76.1 |
|
AWL Agri Business
Mar 2026 |
₹23,802.31 Cr | 187.0 | 21,647 | 293 | +7.5% | - | 1.4% | 82.7 |
All amounts in ₹ Crores